Antipsychotic effects of verapamil in schizophrenia.

Title

Antipsychotic effects of verapamil in schizophrenia.

Creator

Price W A

Publisher

The Hillside journal of clinical psychiatry

Date

1987
1987

Description

The antipsychotic effects of verapamil were tested in a double-blind, placebo-controlled, randomized study in 18 patients who met Research Diagnostic Criteria for acute schizophrenia. The antipsychotic effect of verapamil as measured by the Bunney-Hamburg Global Rating Scale were equal to those of haloperidol. Both verapamil and haloperidol were superior to placebo in decreasing psychotic symptoms. The results indicate that verapamil may have clinical utility in the treatment of schizophrenia.

Subject

Adult; Female; Humans; Male; Middle Aged; Random Allocation; Double-Blind Method; Clinical Trials as Topic; Haloperidol/therapeutic use; Schizophrenia/*drug therapy; Verapamil/*therapeutic use

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

225–230

Issue

2

Volume

9

Citation

Price W A, “Antipsychotic effects of verapamil in schizophrenia.,” NEOMED Bibliography Database, accessed May 7, 2021, https://neomed.omeka.net/items/show/5582.

Social Bookmarking